New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

Segment| Data as of 10/23/2026

BioTech & Genomics ETFs

1D perf

0.3%

1D flows

+$16M

Total AuM

$2.93B

Total ETFs

81 new

Aggregate data of 8 funds

Performance

Flows

	1M	3M	YTD	1Y	3Y	5Y
Perf.	-6.69%	+21.95%	+57.19%	+56.24%	+107.45%
Flows	+$18M	+$254M	+$356M	+$277M	-$334M	-

Top ETFs in this segment

See all

IDNA	1D	-0.31%	1W flows	+$10M	View
PBE	1D	-0.73%	1W flows	+$994K	View
PEPT	1D	-1.49%	1W flows	+$260K	View

Just published in BioTech & Genomics

View all articles

IBB

XBI

Are Biotechnology ETFs In the Midst of a Comeback?

Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.

By Tony Dong, CETF®, Lead ETF Analyst · August 20, 2025

Movers in BioTech & Genomics

Top

Bottom

Top performers, 1 week		1W perf.	YTD perf.
HELX	Franklin Genomic Advancements ETF	+4.49%	+18.42%
ARKG	ARK Genomic Revolution ETF	+3.28%	+65.00%
WDNA	WisdomTree BioRevolution Fund	+3.15%	+35.99%
GNMX	Corgi Genomics & Precision Medicine ETF	+2.63%
PBE	Invesco Dynamic Biotechnology & Genome ETF	+2.60%	+21.44%

Top inflows, 1 week		1W flow	YTD flows
IDNA	iShares Genomics Immunology and Healthcare ETF	+$10M	+$107M
PBE	Invesco Dynamic Biotechnology & Genome ETF	+$994K	+$113M
PEPT	REX Peptide ETF	+$260K	-
GNMX	Corgi Genomics & Precision Medicine ETF	-	-
HELX	Franklin Genomic Advancements ETF	-	+$8M

Data period: October 16 - 23, 2026

Performance lists exclude leveraged and inverse ETFs

Recently launched ETFs

		Inception
PEPT	REX Peptide ETF	10/14/2026

Screener search:

BioTech & Genomics ETFs

Related indexes by ICE

ICEBIO	ICE Biotechnology Index	View on ICE
BTK	NYSE Arca Biotechnology Index	View on ICE
NYFSGIB	NYSE FactSet Global Genomics and Immuno Biopharma Index	View on ICE

Other popular segments

Latest news about Thematic Investing: BioTech & Genomics

IBB

XBI

Are Biotechnology ETFs In the Midst of a Comeback?

Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.

By Tony Dong, CETF®, Lead ETF Analyst · August 20, 2025

IBB

XBI

ARKG

Biotech ETFs – Investing in Health Innovation

With biotech ETFs investors may be able to diversify and gain exposure to biotech companies with less risk and smoother long-term returns.

By Justin Ho · July 21, 2022

Become a better investor with NYSE: The Home of ETFs

Visit the ETF U homepage

ETF Guides

Advantages of ETFs over Mutual Funds1/6

Lower Costs

In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.

Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6

Understanding Leveraged ETFs

Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.

What is a Leveraged ETF?1/6

Introducing Leveraged and Inverse ETFs

In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.